Croda International PLC (GB:50GP)
LSE:50GP
Want to see GB:50GP full AI Analyst Report?
50GP Stock Chart & Stats
78.00 p
5.00 p(6.41%)
At close: 4:00 PM EDT
78.00 p
5.00 p(6.41%)
Day’s Range― - ―
52-Week Range78.00 p - 84.00 p
Previous CloseN/A
Volume302.46K
Average Volume (3M)0.00
Market Cap
£4.29B
Enterprise Value4.85B
Total Cash (Recent Filing)£172.80M
Total Debt (Recent Filing)£696.60M
Price to Earnings (P/E)71.4
Beta0.05
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.11%
Share Statistics
EPS (TTM)0.45
Shares Outstanding616,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.99
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified End Markets & Category OutperformanceStrong, broad-based end-market performance (notably Consumer Care and F&F) signals diversified revenue streams and reduced dependence on any single sector. Durable customer relationships, high retention and regional demand support steady volume and pricing opportunities over the medium term, underpinning revenue resilience through cycles.
Improving Cash Generation And Manageable LeverageConsistent positive operating cash flow and a marked FCF rebound in 2025 improve financial flexibility. Sub- or low‑single digit leverage (~1.3x) and steady capex policy support funding for transformation, dividends and targeted bolt-on M&A without materially stressing the balance sheet over the 2–6 month horizon.
Clear Multi-year Margin And Savings FrameworkA defined three‑year plan with quantified margin, cost‑saving and working capital targets gives a structural roadmap to improved profitability and cash conversion. If executed, these initiatives materially raise sustainable operating margins and ROIC, improving long-term earnings quality and capital return capacity.
Bears Say
Large Exceptional Charges And ImpairmentsMaterial one‑off charges and multiple site impairments reduce reported earnings and balance‑sheet carrying values, creating uncertainty over asset recoverability. These items compress near‑term reported profitability and could presage further restructuring or capital write‑downs that impair long‑term returns.
Weakened Earnings Power And Choppy RevenueA return to choppy top‑line growth and a sustained decline in net income since 2022 indicate underlying earnings volatility. Persistently weaker bottom‑line performance undermines visibility on dividends, ROIC and the company's ability to consistently fund growth or transformation without relying on structural improvements.
Transformation Execution Risk And Near‑term Cash CostsDelivering sizeable savings requires further capex, cash outlays and operational change. Execution risk is significant: failure to realize the planned £100m annualized savings (or timing slippage) would strain margins and cash in the near term and raise the likelihood of further restructuring or lower-than-expected free cash flow.
Croda International News
50GP FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest share price was 78.00 p and its highest was 84.00 p in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is £4.29B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Jul 28, 2026 which is in 40 days.
How were Croda International PLC’s earnings last quarter?
Currently, no data Available
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Overvalued.
Does Croda International PLC pay dividends?
Croda International PLC pays a Semiannually dividend of 2.95 p which represents an annual dividend yield of 7.11%. See more information on Croda International PLC dividends here
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 616,000 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in GB:50GP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Company Description
Croda International PLC
Croda International Plc is a global enterprise specializing in the development, manufacturing, and distribution of high-performance chemicals, with its market reach spanning Europe, the Middle East, Africa, North America, Asia, and Latin America. The company's operations are strategically organized across four main divisions: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's diverse product portfolio caters to numerous sectors. For agriculture, it provides solutions such as crop protection enhancers, seed treatment technologies, animal health compounds, bio-stimulants, and specialized additives for farming films. The industrial landscape benefits from its range of adhesives, lubricant components, protective coatings, polymer solutions, vehicle maintenance chemicals, and advanced additives for plastics, batteries, and catalysts, along with materials for automotive textiles and fibers. Within consumer care, Croda supplies essential ingredients for a broad spectrum of personal care applications, including skin, hair, sun, body, and baby care items, as well as components for cosmetics, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene products. Its Life Sciences segment is a key supplier of active pharmaceutical ingredients, dietary supplements, and various health-related products. The company's expertise also extends to construction chemicals, bitumen additives, and specialized materials and polymer additives vital for electronics and devices. It offers chemistries, emulsifiers, fuel and power generation additives, and unique polymer additives designed for furniture and wood. Furthermore, Croda contributes to household, industrial, and institutional cleaning products, oleochemicals, and chemicals used in packaging, printing, and paper manufacturing, in addition to paints and coatings. A significant area of Croda's innovation lies in thermal management products and advanced bio-based phase change materials, which are critical for temperature control across varied applications, from buildings and apparel to healthcare, electronics, food refrigeration, energy storage, and automotive systems. Established in 1925, Croda International Plc maintains its headquarters in Goole, United Kingdom.